Skip to content

Clinical trials

Hemorrhage trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Hong Kong Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20091
20111
20141
20202
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Idorsia Pharmaceuticals Ltd.2
Takeda2
Abbott Medical Devices1
AstraZeneca1
Boehringer Ingelheim1
Cook Group Incorporated1
Pfizer1
Queen Mary Hospital, Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage10
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemorrhagic Disorders2
Immune System Diseases2
Purpura2
Purpura, Thrombocytopenic2
Purpura, Thrombocytopenic, Idiopathic2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.